Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement
Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.
In this episode of the Pharmaceutical Executive podcast, Bill Grambley, CEO of AllazoHealth, explores:
- How AI can potentially revolutionize patient engagement and adherence
- Utilizing patient-level data and predictive modeling
- How AI can identify individual needs and preferences
- The importance of ethical considerations and data privacy when leveraging AI in healthcare
- and more!
FDA Approves Opdivo Plus Yervoy Regimen for MSI-H/dMMR Colorectal Cancer
April 9th 2025Approval of the Opdivo plus Yervoy combination regimen was based on results from the Phase III CheckMate-8HW trial, which was the largest immunotherapy study in patients with previously untreated, unresectable, or metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
